Existence Genetics | GenomeWeb

Existence Genetics

By Justin Petrone
Existence Genetics, a Los Angeles-based genetic testing company, recently introduced a new service that relies on microarray technology to screen customers for their risk for around 1,000 rare diseases.

New Releases

Premium

Existence Genetics has launched a genetic testing service that analyzes customers' risk for more than 1,000 diseases, traits, and medication reactions in a single run.

The predictive medicine company will use the Oragene DNA saliva-based collection kit.

The company's current technology is based on DNA microarray chips, but its founder and CEO said that once whole-genome sequencing becomes a routine medical procedure, its business model will change and allow the company to truly take off.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.